Published in Pediatr Transplant on October 01, 2005
Pharmacokinetics of cyclosporin--a microemulsion in children with idiopathic nephrotic syndrome. Clinics (Sao Paulo) (2012) 0.75
Effects of making emergency contraception available without a physician's prescription: a population-based study. CMAJ (2005) 2.24
Education of pharmacists in Canada. Am J Pharm Educ (2008) 2.23
Nontypeable Haemophilus influenzae as a pathogen in children. Pediatr Infect Dis J (2009) 2.12
Echo-Doppler assessment of the biophysical properties of the aorta in children with chronic kidney disease. Pediatr Cardiol (2013) 1.98
Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake. Mol Microbiol (2003) 1.87
UDP-glucuronosyltransferases and clinical drug-drug interactions. Pharmacol Ther (2005) 1.80
Unique modifications with phosphocholine and phosphoethanolamine define alternate antigenic forms of Neisseria gonorrhoeae type IV pili. Proc Natl Acad Sci U S A (2004) 1.52
A novel cell-binding mechanism of Moraxella catarrhalis ubiquitous surface protein UspA: specific targeting of the N-domain of carcinoembryonic antigen-related cell adhesion molecules by UspA1. Mol Microbiol (2003) 1.50
Low birth weight and nephron mass and their role in the progression of chronic kidney disease: a case report on identical twins with Alport disease. Nephrol Dial Transplant (2011) 1.45
Is there a role for therapeutic drug monitoring of vitamin D level as a surrogate marker for fracture risk? Pharmacotherapy (2010) 1.44
Evaluation of the research grant program of the Foundation of the Canadian Society of Hospital Pharmacists, 1995-2008. Can J Hosp Pharm (2011) 1.38
Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease. Clin Sci (Lond) (2010) 1.31
Pharmacogenetics of the proton pump inhibitors: a systematic review. Pharmacotherapy (2003) 1.22
Meningococcal interactions with the host. Vaccine (2009) 1.17
The Moraxella adhesin UspA1 binds to its human CEACAM1 receptor by a deformable trimeric coiled-coil. EMBO J (2008) 1.13
Beyond cyclosporine: a systematic review of limited sampling strategies for other immunosuppressants. Ther Drug Monit (2006) 1.10
Fundamentals of population pharmacokinetic modelling: validation methods. Clin Pharmacokinet (2012) 1.10
Genetic and functional analysis of the phosphorylcholine moiety of commensal Neisseria lipopolysaccharide. Mol Microbiol (2002) 1.09
Recognition of saccharides by the OpcA, OpaD, and OpaB outer membrane proteins from Neisseria meningitidis. J Biol Chem (2005) 1.05
Neisseria meningitidis Opc invasin binds to the sulphated tyrosines of activated vitronectin to attach to and invade human brain endothelial cells. PLoS Pathog (2010) 1.04
Clinical practice guidelines for evidence-based use of erythropoietic-stimulating agents. Kidney Int Suppl (2008) 1.02
The role of therapeutic drug monitoring of imatinib in patients with chronic myeloid leukemia and metastatic or unresectable gastrointestinal stromal tumors. Ther Drug Monit (2012) 1.01
Meningococcal surface fibril (Msf) binds to activated vitronectin and inhibits the terminal complement pathway to increase serum resistance. Mol Microbiol (2011) 1.01
Carcinoembryonic antigen-related cell adhesion molecule (CEACAM)-binding recombinant polypeptide confers protection against infection by respiratory and urogenital pathogens. Mol Microbiol (2005) 1.01
Clinical pharmacokinetic monitoring of itraconazole is warranted in only a subset of patients. Ther Drug Monit (2005) 1.01
Prevalence and correlates of multiple cardiovascular risk factors in children with chronic kidney disease. Clin J Am Soc Nephrol (2011) 1.00
Atovaquone-proguanil for prophylaxis and treatment of malaria. Ann Pharmacother (2003) 0.99
Pharmacokinetics and drug dosing in obese children. J Pediatr Pharmacol Ther (2010) 0.97
Corticosteroid interactions with cyclosporine, tacrolimus, mycophenolate, and sirolimus: fact or fiction? Ann Pharmacother (2008) 0.97
Co-ordinate action of bacterial adhesins and human carcinoembryonic antigen receptors in enhanced cellular invasion by capsulate serum resistant Neisseria meningitidis. Cell Microbiol (2006) 0.97
Efavirenz and nevirapine in HIV-1 infection : is there a role for clinical pharmacokinetic monitoring? Clin Pharmacokinet (2007) 0.95
Stability of Extemporaneously Compounded Naproxen 25 mg/mL Suspension in Glass and Plastic Bottles and Plastic Syringes. Can J Hosp Pharm (2015) 0.95
Characterization of epithelial IL-8 response to inflammatory bowel disease mucosal E. coli and its inhibition by mesalamine. Inflamm Bowel Dis (2008) 0.95
Canadian Society of Nephrology commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD. Am J Kidney Dis (2013) 0.95
Opa+ and Opa- isolates of Neisseria meningitidis and Neisseria gonorrhoeae induce sustained proliferative responses in human CD4+ T cells. Infect Immun (2009) 0.94
Mosquirix (RTS,S): a novel vaccine for the prevention of Plasmodium falciparum malaria. Ann Pharmacother (2012) 0.94
IFN-gamma amplifies NFkappaB-dependent Neisseria meningitidis invasion of epithelial cells via specific upregulation of CEA-related cell adhesion molecule 1. Cell Microbiol (2007) 0.93
Neisseria meningitidis Opc invasin binds to the cytoskeletal protein alpha-actinin. Cell Microbiol (2008) 0.93
Pharmacokinetics of antimalarials in pregnancy: a systematic review. Clin Pharmacokinet (2011) 0.92
Clinical practice guidelines for assessment and management of iron deficiency. Kidney Int Suppl (2008) 0.92
Stability of clonidine suspension in oral plastic syringes. Am J Health Syst Pharm (2014) 0.92
Critical determinants of the interactions of capsule-expressing Neisseria meningitidis with host cells: the role of receptor density in increased cellular targeting via the outer membrane Opa proteins. Cell Microbiol (2005) 0.92
Pharmacokinetics of intravenous immunoglobulin: a systematic review. Pharmacotherapy (2006) 0.92
Outcomes of bupropion therapy for smoking cessation during routine clinical use. Ann Pharmacother (2006) 0.91
Mutational analysis of human CEACAM1: the potential of receptor polymorphism in increasing host susceptibility to bacterial infection. Cell Microbiol (2006) 0.91
Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. Am J Obstet Gynecol (2005) 0.91
A systematic review of the pharmacokinetics of antiepileptic drugs in neonates with refractory seizures. J Pediatr Pharmacol Ther (2012) 0.91
Comparing outcomes of meropenem administration strategies based on pharmacokinetic and pharmacodynamic principles: a qualitative systematic review. Ann Pharmacother (2010) 0.90
Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK Statement. Clin Pharmacokinet (2015) 0.90
Development and validation of a novel vancomycin dosing nomogram for achieving high-target trough levels at 2 canadian teaching hospitals. Can J Hosp Pharm (2012) 0.90
Carotid intima-media thickness in children with CKD: results from the CKiD study. Clin J Am Soc Nephrol (2012) 0.90
Primary renal zygomycotic infarction mimicking renal neoplasia in an immunocompetent patient. Am J Med Sci (2009) 0.90
The utility of therapeutic drug monitoring for ribavirin in patients with chronic hepatitis C--a critical review. Ann Pharmacother (2009) 0.89
Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin. J Obstet Gynaecol Can (2004) 0.89
Clinical pharmacokinetic monitoring of midazolam in critically ill patients. Pharmacotherapy (2007) 0.89
Systematic review of efficacy, pharmacokinetics, and administration of intraventricular vancomycin in adults. Neurocrit Care (2014) 0.89
Ganciclovir in solid organ transplant recipients: is there a role for clinical pharmacokinetic monitoring? Ther Drug Monit (2004) 0.88
Fundamentals of population pharmacokinetic modelling: modelling and software. Clin Pharmacokinet (2012) 0.88
Mycophenolate mofetil for solid organ transplantation: does the evidence support the need for clinical pharmacokinetic monitoring? Ther Drug Monit (2003) 0.88
Involvement of the autophagy pathway in trafficking of Mycobacterium tuberculosis bacilli through cultured human type II epithelial cells. Cell Microbiol (2012) 0.87
Addition of rifampin to vancomycin for methicillin-resistant Staphylococcus aureus infections: what is the evidence? Ann Pharmacother (2013) 0.86
Vancomycin-induced neutropenia: is it dose- or duration-related? Ann Pharmacother (2011) 0.86
Pharmacogenetics of risperidone: a systematic review of the clinical effects of CYP2D6 polymorphisms. Ann Pharmacother (2013) 0.85
Pharmacokinetic effects of bariatric surgery. Ann Pharmacother (2011) 0.85
Belatacept: a new biologic and its role in kidney transplantation. Ann Pharmacother (2012) 0.85
Outcome of kidney transplantation in Canadian Aboriginal children in the province of British Columbia. Pediatr Transplant (2008) 0.85
A comprehensive review on the pharmacokinetics of antibiotics in interstitial fluid spaces in humans: implications on dosing and clinical pharmacokinetic monitoring. Clin Pharmacokinet (2014) 0.84
Sirolimus: the evidence for clinical pharmacokinetic monitoring. Clin Pharmacokinet (2005) 0.84
A critical review: does thiopental continuous infusion warrant therapeutic drug monitoring in the critical care population? Ther Drug Monit (2009) 0.84
Pharmacokinetic profile of artemisinin derivatives and companion drugs used in artemisinin-based combination therapies for the treatment of Plasmodium falciparum malaria in children. Clin Pharmacokinet (2013) 0.83
Evaluating outcomes associated with alternative dosing strategies for piperacillin/tazobactam: a qualitative systematic review. Ann Pharmacother (2012) 0.83
Dexamethasone 1 mg/mL Suspension Prepared from Crushed Tablets: Stability in Glass and Plastic Bottles and Plastic Syringes. Can J Hosp Pharm (2016) 0.83
Systemic lupus erythematosus and other autoimmune disorders in children with Noonan syndrome. Am J Med Genet A (2005) 0.83
Introduction to the Canadian Society of Nephrology clinical practice guidelines for the management of anemia associated with chronic kidney disease. Kidney Int Suppl (2008) 0.83
Haloperidol dosing strategies in the treatment of delirium in the critically ill. Neurocrit Care (2012) 0.82
An outbreak of diarrhea-associated childhood hemolytic uremic syndrome: the Walkerton epidemic. Kidney Int Suppl (2009) 0.82
The role of therapeutic monitoring of everolimus in solid organ transplantation. Ther Drug Monit (2005) 0.82
Therapeutic drug monitoring in interstitial fluid: a feasibility study using a comprehensive panel of drugs. J Pharm Sci (2012) 0.82
Sirolimus pharmacokinetics in pediatric renal transplant recipients receiving calcineurin inhibitor co-therapy. Pediatr Transplant (2006) 0.81
Telaprevir: clinical pharmacokinetics, pharmacodynamics, and drug-drug interactions. Clin Pharmacokinet (2013) 0.81
Correlation of in situ mechanosensitive responses of the Moraxella catarrhalis adhesin UspA1 with fibronectin and receptor CEACAM1 binding. Proc Natl Acad Sci U S A (2011) 0.81
Utility of anti-xa monitoring in children receiving enoxaparin for therapeutic anticoagulation. J Pediatr Pharmacol Ther (2005) 0.81
Effect of the UGT1A1*28 allele on unconjugated hyperbilirubinemia in HIV-positive patients receiving Atazanavir: a systematic review. Ann Pharmacother (2013) 0.81
Dosing and monitoring of methadone in pregnancy: literature review. Can J Hosp Pharm (2012) 0.81
A novel group of Moraxella catarrhalis UspA proteins mediates cellular adhesion via CEACAMs and vitronectin. PLoS One (2012) 0.81
Hepcidin and risk of anemia in CKD: a cross-sectional and longitudinal analysis in the CKiD cohort. Pediatr Nephrol (2014) 0.81
Pharmacogenetic impact of UDP-glucuronosyltransferase metabolic pathway and multidrug resistance-associated protein 2 transport pathway on mycophenolic acid in thoracic transplant recipients: an exploratory study. Pharmacotherapy (2010) 0.81
Limited sampling strategies for mycophenolic acid in solid organ transplantation: a systematic review. Expert Opin Drug Metab Toxicol (2009) 0.81
Does oxcarbazepine warrant therapeutic drug monitoring? A critical review. Clin Pharmacokinet (2008) 0.80
Does valproic acid warrant therapeutic drug monitoring in bipolar affective disorder? Ther Drug Monit (2010) 0.80
Fluoxetine in the treatment of premenstrual dysphoric disorder. Ann Pharmacother (2002) 0.80
A systematic review of limited sampling strategies for platinum agents used in cancer chemotherapy. Clin Pharmacokinet (2007) 0.80
Comparison of vancomycin concentrations in blood and interstitial fluid: a possible model for less invasive therapeutic drug monitoring. Clin Chem Lab Med (2011) 0.80
Hepcidin in anemia of chronic kidney disease: review for the pediatric nephrologist. Pediatr Nephrol (2011) 0.80
Stability of Levothyroxine in Sodium Chloride for IV Administration. Can J Hosp Pharm (2010) 0.80
Malignant hypertension, polycythemia, and paragangliomas. J Pediatr (2006) 0.80
Meningococcal ligands and molecular targets of the host. Methods Mol Biol (2012) 0.80
Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients. Ther Drug Monit (2008) 0.80
Renal leiomyoma associated with Epstein-Barr virus in a pediatric transplant patient. Am J Kidney Dis (2005) 0.80